Chronic Use of Triazolam: The Effects on the Sleep Patterns of Insomniacs
The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
The present study was designed to evaluate the effects of triazolam 0.5 mg on the sleep of insomniac patients when given for 3 weeks. The results showed that both acute and chronic triazolam administration are effective in decreasing sleep latency, increasing sleep duration, increasing sleep efficiency and decreasing total wake time without producing major effects on sleep staging. Sleep Stages 1 and 2 were significantly altered by drug treatment but in a positive direction. This change is primarily attributable to the significant decrease in sleep onset. Deep sleep and REM were not significantly changed during triazolam treatment nor was there any evidence of REM rebound after discontinuation of the medication. It was noted that some of the sleep parameters measured shifted toward baseline measures in the first night after triazolam treatment was terminated. However, the total recovery period recorded (7 days) showed the quality and quantity of sleep obtained to be improved over baseline measures. The recovery data compared favourably with those improvements noted during chronic administration of triazolam. It was also found that 3 weeks of triazolam 0.5 mg usage did not result in tolerance to its hypnotic properties. Thus, triazolam maintains its hypnotic effectiveness throughout 3 weeks of administration.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, conflicting studies with triazolam exist that did not show any tolerance development [44, 45].”
From Mechanisms Underlying Tolerance after Long-Term Benzodiazepine Use: A Future for Subtype-Selective Receptor Modulators? (2012) · cites this paper as [44]
Citations
Cites
Rechtschaffen, A. (1968) · Medical Entomology and Zoology · Cited by 12,654
Allan Hobson, J. (1969) · Electroencephalography and Clinical Neurophysiology · doi:10.1016/0013-4694(69)90021-2 · Cited by 5,192
Hypnotic Efficacy of Triazolam: Sleep Laboratory Evaluation of Intermediate‐Term Effectiveness
KALES, A., KALES, J. D., BIXLER, E. O., SCHARF, M. B., & RUSSEK, E. (1976) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1976.tb02414.x · Cited by 99
The effect of triazolam on the sleep of insomniacs
VOGEL, G., Thurmond, A., Gibbons, P., Edwards, K. N., Sloan, K. B., & Sexton, K. (1975) · Psychopharmacology · doi:10.1007/bf00421308 · Cited by 74
Intermediate Use of Triazolam: A Sleep Laboratory Study
Roth, T., Kramer, M., & Lutz, T. (1976) · Journal of International Medical Research · doi:10.1177/030006057600400109 · Cited by 60
Comparison of Triazolam, Flurazepam, and Placebo as Hypnotics in Geriatric Patients with Insomnia
REEVES, R. I. (1977) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1977.tb04611.x · Cited by 46 · cited 2×
“Triazolam did not significantly alter total time spent in Stage REM, however REM latency was significantly longer. Stages 1 and 3-4 showed no significant effect due to drug condition. In a sleep laboratory study designed to evaluate the effect of intermediate administration of triazolam 0·5 mg on the sleep of insomnia…”
MethodResultTriazolam: a sleep laboratory study of a new benzodiazepine hypnotic.
Roth, T. G., Krämer, M., & Jl, S. (1974) · PubMed · Cited by 38
Long‐Term Hypnotic Efficacy and Safety of Triazolam and Flurazepam
LEIBOWITZ, M., & SUNSHINE, A. (1978) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1978.tb02450.x · Cited by 37
(2002) · Clinical Therapeutics · doi:10.1016/s0149-2918(02)80054-6 · Cited by 37
Sleep disturbance and hypnotic drug dependence
Clift, A. D. (1975) · Medical Entomology and Zoology · Cited by 35
Research works printed but not linked: 2
- Chatwin J C, 1976, Current Therapeutic Research, 21, 207
- Roth T, 1974, Current Therapeutic Research, 16, 117
Cited by
Sleep and Psychiatric Disorders: A Meta-analysis
Benca, R. M. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820080059010 · Cited by 1,468
Kanto, J. H. (1985) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1985.tb03411.x · Cited by 237
Vinkers, C. H., & Olivier, B. (2012) · Advances in Pharmacological Sciences · doi:10.1155/2012/416864 · Cited by 195
“However, conflicting studies with triazolam exist that did not show any tolerance development [44, 45].”
BackgroundPakes, G. E., Brogden, R. N., Heel, R. C., Speight, T. M., & Avery, G. S. (1981) · Drugs · doi:10.2165/00003495-198122020-00001 · Cited by 163
Obermeyer, W. H., & Benca, R. M. (1996) · Neurologic Clinics · doi:10.1016/s0733-8619(05)70287-5 · Cited by 118
Metadata
- Authors
- Pegram, V., Hyde, P., & Linton, P.
- Affiliations
- University of Alabama (US)
- ORCID
- Linton, Patrick
- Venue
- Journal of International Medical Research
- Publisher
- SAGE Publications
- Published
- 1980-05
- Volume
- 8
- Issue
- 3
- Pages
- 224-231
- ISSN
- 0300-0605 (ISSN-L)
- 1473-2300
- OpenAlex
- W1832358695
- Cited by
- 29
- References
- 14
- Citations by year
- 2024: 1 · 2022: 1 · 2012: 1
- FWCI
- 4.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of International Medical Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
- Life Sciences › Neuroscience › Cognitive Neuroscience › Sleep and Wakefulness Research
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and Work-Related Fatigue
- Keywords
- triazolam, insomnia, hypnotics, chronic drug use, sleep latency, sleep duration, sleep efficiency, sleep stages, REM sleep, REM rebound
- MeSH terms
- Adolescent, Adult, Clinical Trials as Topic, Double-Blind Method, Female, Humans, Sleep Initiation and Maintenance Disorders, Male, Middle Aged, Placebos, Sleep Stages, Anti-Anxiety Agents, Triazolam
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Chronic Use of Triazolam: The Effects on the Sleep Patterns of Insomniacs. https://app.cochat.ai/papers/10.1177/030006058000800308
- The paper
- Pegram, V., Hyde, P., & Linton, P. (1980). Chronic Use of Triazolam: The Effects on the Sleep Patterns of Insomniacs. Journal of International Medical Research. https://doi.org/10.1177/030006058000800308
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.